|
IFT57 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.880400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.991400E-01 |
| Normal-vs-Stage2 |
7.536200E-01 |
| Normal-vs-Stage3 |
6.775600E-01 |
| Normal-vs-Stage4 |
1.935140E-03 |
| Stage1-vs-Stage2 |
5.674000E-01 |
| Stage1-vs-Stage3 |
4.986800E-01 |
| Stage1-vs-Stage4 |
2.258600E-03 |
| Stage2-vs-Stage3 |
9.958200E-01 |
| Stage2-vs-Stage4 |
1.135240E-01 |
| Stage3-vs-Stage4 |
5.492300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.160800E-01 |
| Normal-vs-AfricanAmerican |
4.869200E-01 |
| Normal-vs-Asian |
2.625200E-01 |
| Caucasian-vs-AfricanAmerican |
6.836800E-01 |
| Caucasian-vs-Asian |
2.688000E-01 |
| AfricanAmerican-vs-Asian |
1.782220E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.280200E-01 |
| Normal-vs-Female |
2.384800E-01 |
| Male-vs-Female |
1.666400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.125600E-01 |
| Normal-vs-Extreme_Weight |
8.339000E-01 |
| Normal-vs-Obese |
8.831600E-01 |
| Normal-vs-Extreme_Obese |
9.242600E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.486400E-01 |
| Normal_Weight-vs-Obese |
3.008600E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.568600E-01 |
| Extreme_Weight-vs-Obese |
7.613400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.456400E-01 |
| Obese-vs-Extreme_Obese |
9.579800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.325800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.769210E-01 |
| Normal-vs-Age(61-80Yrs) |
5.966400E-01 |
| Normal-vs-Age(81-100Yrs) |
6.591800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.587200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.763600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.131000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.334200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.461400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.522800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.455200E-03 |
| Normal-VS-Type2 PRCC |
1.897790E-03 |
| Normal-VS-KIRP CIMP |
6.029600E-02 |
| Normal-VS-Unclassified PRCC |
9.130600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.27439999956181E-08 |
| Type1 PRCC-VS-KIRP CIMP |
3.164600E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
7.128200E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.031800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.175600E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.949170E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.288500E-02 |
| Normal-vs-N1 |
9.511000E-01 |
| Normal-vs-N2 |
3.475300E-03 |
| N0-vs-N1 |
2.434800E-01 |
| N0-vs-N2 |
3.827600E-01 |
| N1-vs-N2 |
1.197190E-01 |
|
|
